Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children

John T Wiernikowski1, Stuart MacLeod,

  • 1Pediatric Hematology/Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Insights

Global drug shortages and regulations impede children's access to essential medicines, particularly in low-income nations. Enhanced international collaboration is crucial to overcome these barriers for pediatric cancer treatments.

Area of Science:

  • Pediatric pharmacology
  • Global health policy
  • Drug accessibility

Background:

  • Numerous logistical, regulatory, and drug shortage issues globally hinder pediatric access to essential medicines.
  • These barriers disproportionately affect low and middle-income countries and children with life-threatening conditions like cancer.
  • While progress has been made through international organizations and regulatory bodies, challenges persist.

Purpose of the Study:

  • To highlight the significant impediments to pediatric access to therapeutic drugs worldwide.
  • To emphasize the critical need for international collaboration in addressing these access barriers.
  • To focus on the specific challenges in providing antineoplastic and supportive care medicines for children.

Main Methods:

  • Review of global pharmaceutical access challenges.
  • Analysis of regulatory and logistical barriers.
  • Examination of the impact of international trade regulations on drug availability.

Main Results:

  • Identified significant global barriers including logistical, regulatory, and drug shortages affecting pediatric drug access.
  • Noted detrimental effects of World Trade Organization regulations on drug availability in low and middle-income countries.
  • Highlighted progress made by organizations like the World Health Organization in fostering pediatric drug development and data.

Conclusions:

  • Closer international collaboration is essential to overcome existing barriers.
  • Addressing these impediments is vital for improving access to antineoplastic and supportive care medicines for children globally.
  • Continued efforts are needed to ensure equitable access to pediatric therapeutics worldwide.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K